. home.aspx



CivicaRx's first CEO, Martin VanTrieste, talks about the company's ambitions for 2019 and beyond

December 06, 2018 / Tina Reed

When Martin VanTrieste left his executive role at AmGen, he said he was retiring. He’d started out as a pharmacist, working in formulation development for a large pharmaceutical company, and went on to ultimately become the chief quality officer of a drug giant. But earlier this year, he jumped on an intriguing opportunity: A group of hospitals wanted to start a drug company in order to stabilize the availability and cost of life-saving generic drugs called CivicaRX. Van Trieste agreed to lead it without drawing a salary. “I always felt a desire to serve patients. It’s always been how I operate,” VanTrieste said. “This was an opportunity where I could give back and serve patients.”